公司资料
Rockwell Medical 股价、新闻与催化剂
- 股票代码:
- RMTI
- 交易所:
- NASDAQ
- 行业:
- Biopharma
- 所在地:
- United States
股票表现
7.49 USD (+1.01%)
收盘价
最后更新: 2026年8月17日
28M USD
市值
股价为何变动
As of Aug 17, 2026, RMTI closed up 1.01% at $7.49. No new same-company headline was identified in the current news window.
公司概览
业务概览
Rockwell Medical is a specialty pharmaceutical and device company focused on iron management and dialysis care. Its business is centered on products used in renal treatment settings.
所在地与行业分类
Headquartered in the United States and listed on NASDAQ, Rockwell sits in specialty biopharma and renal care.
商业模式特征
The company depends on product adoption, dialysis-market access, and the economics of renal treatment workflows.
生物医药行业定位
Rockwell is a niche renal-care company whose stock moves on commercial execution and product use.
未来催化剂
- Rockwell Medical’s catalysts are dialysis-iron demand, manufacturing execution, and continued commercialization of Triferic and related products. Investors will watch whether recurring dialysis workflows keep supporting the story.
近期新闻
- 01
- 02
- 03
- 04
- 05
相似股票
商业成熟度、治疗领域或催化剂模式相近的同行公司。